Walgreens makes progress on turnaround in Q1, though losses grow
Despite a $265 million net loss, investors saw reason for optimism in the quarter, including renegotiated pharmacy contracts and the closure of 70 underperforming stores.
Despite a $265 million net loss, investors saw reason for optimism in the quarter, including renegotiated pharmacy contracts and the closure of 70 underperforming stores.